State Street’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.7M | Sell |
3,224,306
-58,969
| -2% | -$1.7M | ﹤0.01% | 1346 |
|
|
2025
Q1 | $110M | Buy |
3,283,275
+292,437
| +10% | +$9.81M | ﹤0.01% | 1206 |
|
|
2024
Q4 | $153M | Buy |
2,990,838
+152,354
| +5% | +$7.79M | 0.01% | 1087 |
|
|
2024
Q3 | $145M | Buy |
2,838,484
+25,561
| +0.9% | +$1.31M | 0.01% | 1105 |
|
|
2024
Q2 | $126M | Sell |
2,812,923
-442,330
| -14% | -$19.8M | 0.01% | 1123 |
|
|
2024
Q1 | $152M | Sell |
3,255,253
-308,483
| -9% | -$14.4M | 0.01% | 1035 |
|
|
2023
Q4 | $127M | Buy |
3,563,736
+711,016
| +25% | +$25.3M | 0.01% | 1142 |
|
|
2023
Q3 | $84.8M | Buy |
2,852,720
+614,985
| +27% | +$18.3M | ﹤0.01% | 1292 |
|
|
2023
Q2 | $40.3M | Buy |
2,237,735
+18,941
| +0.9% | +$341K | ﹤0.01% | 1798 |
|
|
2023
Q1 | $35.6M | Buy |
2,218,794
+214,010
| +11% | +$3.44M | ﹤0.01% | 1860 |
|
|
2022
Q4 | $36.7M | Buy |
2,004,784
+196,119
| +11% | +$3.59M | ﹤0.01% | 1846 |
|
|
2022
Q3 | $35.5M | Buy |
1,808,665
+47,820
| +3% | +$939K | ﹤0.01% | 1841 |
|
|
2022
Q2 | $32.8M | Buy |
1,760,845
+60,166
| +4% | +$1.12M | ﹤0.01% | 1911 |
|
|
2022
Q1 | $37.3M | Buy |
1,700,679
+400,305
| +31% | +$8.79M | ﹤0.01% | 1936 |
|
|
2021
Q4 | $36.9M | Buy |
1,300,374
+184,515
| +17% | +$5.24M | ﹤0.01% | 2024 |
|
|
2021
Q3 | $23.5M | Buy |
1,115,859
+569,427
| +104% | +$12M | ﹤0.01% | 2363 |
|
|
2021
Q2 | $10.3M | Buy |
546,432
+73,871
| +16% | +$1.39M | ﹤0.01% | 2908 |
|
|
2021
Q1 | $7.22M | Sell |
472,561
-8,238
| -2% | -$126K | ﹤0.01% | 2885 |
|
|
2020
Q4 | $6.78M | Buy |
480,799
+37,024
| +8% | +$522K | ﹤0.01% | 2815 |
|
|
2020
Q3 | $6.95M | Buy |
443,775
+24,800
| +6% | +$389K | ﹤0.01% | 2637 |
|
|
2020
Q2 | $7.34M | Buy |
418,975
+194,481
| +87% | +$3.41M | ﹤0.01% | 2575 |
|
|
2020
Q1 | $3.3M | Sell |
224,494
-2,107
| -0.9% | -$31K | ﹤0.01% | 2825 |
|
|
2019
Q4 | $5.69M | Buy |
226,601
+20,305
| +10% | +$509K | ﹤0.01% | 2789 |
|
|
2019
Q3 | $3.1M | Buy |
206,296
+2,668
| +1% | +$40.1K | ﹤0.01% | 3036 |
|
|
2019
Q2 | $5.09M | Buy |
203,628
+98,229
| +93% | +$2.46M | ﹤0.01% | 2811 |
|
|
2019
Q1 | $2.4M | Buy |
105,399
+2,251
| +2% | +$51.2K | ﹤0.01% | 3081 |
|
|
2018
Q4 | $3.09M | Buy |
103,148
+26,769
| +35% | +$803K | ﹤0.01% | 2935 |
|
|
2018
Q3 | $2.19M | Buy |
+76,379
| New | +$2.19M | ﹤0.01% | 3213 |
|